Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation

Bioorg Med Chem Lett. 2018 Apr 1;28(6):1011-1019. doi: 10.1016/j.bmcl.2018.02.031. Epub 2018 Feb 16.

Abstract

Here we report the synthesis and in vitro evaluation of 25 new quinolinyl analogues for α-synuclein aggregates. Three lead compounds were subsequently labeled with carbon-11 or fluorine-18 to directly assess their potency in a direct radioactive competitive binding assay ng both α-synuclein fibrils and tissue homogenates from Alzheimer's disease (AD) cases. The modest binding affinities of these three radioligands toward α-synuclein were comparable with results from the Thioflavin T fluorescence assay. However, all three ligand also showed modest binding affinity to the AD homogenates and lack selectivity for α-synuclein. The structure-activity relationship data from these 25 analogues will provide useful information for design and synthesis of new compounds for imaging α-synuclein aggregation.

Keywords: PET radiotracer; Parkinson’s disease; Quinolinyl analogue; Radiosynthesis; Thioflavin T fluorescence assay; α-Synuclein fibrils.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Design*
  • Molecular Structure
  • Protein Aggregates / drug effects
  • Quinolines / chemical synthesis
  • Quinolines / chemistry
  • Quinolines / pharmacology*
  • Structure-Activity Relationship
  • alpha-Synuclein / antagonists & inhibitors*

Substances

  • Protein Aggregates
  • Quinolines
  • alpha-Synuclein